150 related articles for article (PubMed ID: 2831559)
1. Positive scintigraphy of medullary thyroid cancer using 201Tl and alkalized 99mTc-DMSA.
Holub V; Nĕmec J; Neradilová M; Benová M; Blazek T; Dusek M
Radiobiol Radiother (Berl); 1987; 28(5):640-2. PubMed ID: 2831559
[No Abstract] [Full Text] [Related]
2. More on [99mTc](V)DMSA scintigraphy in patients with medullary carcinoma of the thyroid.
Mojiminiyi OA; Udelsman R; Shepstone BJ; Dudley NE; Soper ND
J Nucl Med; 1989 Aug; 30(8):1420. PubMed ID: 2547036
[No Abstract] [Full Text] [Related]
3. Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid.
Hilditch TE; Murray T; Connell JM; McLellan AR; Reed NS
J Nucl Med; 1988 Oct; 29(10):1746-7. PubMed ID: 2845025
[No Abstract] [Full Text] [Related]
4. Tc-99m DMSA scintigraphy on patients with medullary thyroid carcinoma.
Groth P; Unterspann S; Schwähn D; Stoll I; Reincke R
Radiobiol Radiother (Berl); 1987; 28(5):642-4. PubMed ID: 2831560
[No Abstract] [Full Text] [Related]
5. Technetium-99m(V)-DMSA in the imaging of medullary thyroid carcinoma.
J Nucl Med; 1987 Feb; 28(2):252-3. PubMed ID: 3027281
[No Abstract] [Full Text] [Related]
6. The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MTC).
Guerra U; Pizzocaro C; Terzi A; Giubbini R; Bestagno M
J Nucl Med Allied Sci; 1988; 32(4):242-7. PubMed ID: 2852709
[No Abstract] [Full Text] [Related]
7. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus CR; Wraight P; Sampson C; Maisey MN
J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723
[TBL] [Abstract][Full Text] [Related]
8. [Scintigraphy of medullary carcinoma of the thyroid by new radiopharmaceuticals].
Tada J; Konishi J; Torizuka K; Makimoto K; Miyauchi A
Rinsho Hoshasen; 1984 Sep; 29(9):1043-4. PubMed ID: 6096600
[No Abstract] [Full Text] [Related]
9. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid.
Clarke SE; Lazarus C; Mistry R; Maisey MN
Br J Radiol; 1987 Nov; 60(719):1089-92. PubMed ID: 2825895
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of 99mTc(V)-dimercapto succinic acid (DMSA) for imaging medullary carcinoma of thyroid and its metastasis.
Patel MC; Patel RB; Ramanathan P; Ramamoorthy N; Krishna BA; Sharma SM
Eur J Nucl Med; 1988; 13(10):507-10. PubMed ID: 2836203
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of 99mTc(V)-DMSA complex: studies in medullary carcinoma of thyroid.
Ramamoorthy N; Shetye SV; Pandey PM; Mani RS; Patel MC; Patel RB; Ramanathan P; Krishna BA; Sharma SM
Eur J Nucl Med; 1987; 12(12):623-8. PubMed ID: 3034614
[TBL] [Abstract][Full Text] [Related]
12. Radionuclide imaging in medullary thyroid carcinoma: evaluation of two new radiopharmaceuticals.
Clarke SE; Lazarus CR; Maisey MN
Henry Ford Hosp Med J; 1987; 35(2-3):124-6. PubMed ID: 2826368
[No Abstract] [Full Text] [Related]
13. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid.
Ugur O; Kostakğlu L; Güler N; Caner B; Uysal U; Elahi N; Haliloğlu M; Yüksel D; Aras T; Bayhan H; Bekdik C
Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m pentavalent DMSA imaging detects metastases of poorly differentiated carcinoma of the thyroid.
Costa DC; Glynne-Jones R; Falzon M; Lui D; Ryder JP; Ell PJ
Clin Nucl Med; 1989 Mar; 14(3):218-21. PubMed ID: 2544341
[No Abstract] [Full Text] [Related]
16. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
17. Preparation and clinical evaluation of technetium-99m dimercaptosuccinic acid for tumour scintigraphy.
Hirano T; Tomiyoshi K; Zhang YJ; Ishida T; Inoue T; Endo K
Eur J Nucl Med; 1994 Jan; 21(1):82-5. PubMed ID: 8088289
[TBL] [Abstract][Full Text] [Related]
18. A new imaging agent for medullary carcinoma of the thyroid.
Ohta H; Yamamoto K; Endo K; Mori T; Hamanaka D; Shimazu A; Ikekubo K; Makimoto K; Iida Y; Konishi J
J Nucl Med; 1984 Mar; 25(3):323-5. PubMed ID: 6321700
[TBL] [Abstract][Full Text] [Related]
19. [Medullary carcinoma of the thyroid and 99mTc(V)-DMSA scintigraphy. Clinical results with a new radiopharmaceutical].
Kujat C; Neidl K; Müller-Leisse C
Rofo; 1990 Nov; 153(5):495-500. PubMed ID: 2173051
[TBL] [Abstract][Full Text] [Related]
20. Poor results with technetium-99m (V) DMS and iodine-131 MIBG in the imaging of medullary thyroid carcinoma.
Hilditch TE; Connell JM; Elliot AT; Murray T; Reed NS
J Nucl Med; 1986 Jul; 27(7):1150-3. PubMed ID: 3014086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
